Beroni Group Limited BNIGF
0.01 USD 0.00 (+0.00%)
Regular-session close
0.0021 Day range 0.0021
0.0021 52-week range 0.0064
- YTD
- 0.00%
- 1 year
- 0.00%
News
globenewswire.com Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO NEW YORK and SYDNEY, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise, announced that PENAO…
globenewswire.com Beroni Group Issues US$2 Million of Convertible Notes to Fund Research and Development Plans NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today…
globenewswire.com Beroni Group's SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit NEW YORK and SYDNEY, Australia, April 27, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today…
globenewswire.com Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company NEW YORK and SYDNEY, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announces that it…